Stewart Abbot serves as Executive at FATE THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Stewart Abbot has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 15, 2018 involved exercising options for 18,138 shares valued at $125.2K.
Stewart Abbot currently holds 64,917 shares of FATE THERAPEUTICS INC (FATE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stewart Abbot has been a net neutral trader of FATE stock. They have purchased $0 and sold $0 worth of shares.
Stewart Abbot's most recent insider trade was on May 15, 2018, when they sold 18,138 shares at $6.90 per share.
Get notified when new Form 4 filings are submitted
| 2,916 |
| $4.89 |
| Discretionary |
| Jan 8, 2016 | FATE | $0 | Award | 3,863 | $N/A | Discretionary |
| Oct 15, 2015 | FATE | $0 | Award | 40,000 | $N/A | Discretionary |